CritCareCardio(@CritCareCardio) 's Twitter Profileg
CritCareCardio

@CritCareCardio

https://t.co/VOTNLBLkM2 Adham M Karim, MD #AHAEarlyCareerBlogger @CaseUHMed @Kentucky_Cards alum- All tweets are my own -

ID:1093924369091448832

calendar_today08-02-2019 17:27:48

143 Tweets

431 Followers

268 Following

Sandeep Nathan, MD, MSc(@SandeepNathanMD) 's Twitter Profile Photo

80 yo pt w/HTN, DM, HF recovered EF (45-50%) CAD, NASH & diverticular bleed 1 yr ago presents w crushing CP, HR 40, BP 90/50/63 MAP. DAPT+UFH in ED. ECG c/w inf STEMI; angio & still images👇🏽. What’s your preferred approach ?

account_circle
Pradeep Natarajan(@pnatarajanmd) 's Twitter Profile Photo

Great option for those taking CV meds! Great mission! Mark Cuban

Lisinopril $3.60 (retail $24)
Losartan $4.50 ($27.90)
Valsartan $9.90 ($69)
Clopidogrel $5.70 ($60.30)
Furosemide $4.20 ($8.70)
Atorvastatin $3.60 ($55.08)
Spironolactone $4.20 ($14.40)
Metformin $3.90 ($20.10)

account_circle
Gregg Fonarow MD(@gcfmd) 's Twitter Profile Photo

Placing HFrEF in the context of other medical conditions may make the “extreme high-risk” and “very extreme high-risk” nature of HFrEF more readily apparent; lead to greater prioritization of HF prevention and treatment efforts

Contextualizing Risk in HF ja.ma/3IRItEY

Placing HFrEF in the context of other medical conditions may make the “extreme high-risk” and “very extreme high-risk” nature of HFrEF more readily apparent; lead to greater prioritization of HF prevention and treatment efforts Contextualizing Risk in HF ja.ma/3IRItEY
account_circle
CritCareCardio(@CritCareCardio) 's Twitter Profile Photo

Great session at on - there’s more to the story than angiographic appearance or FFR. Plaque morphology should play a role. Excited to see more trials in the future.

account_circle